1. ScholarBank@NUS

Shao Peng, David Tan

rp27124

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Shao Peng, David Tan
Variants
Tan, David S.P.
 
Main Affiliation
 
Faculty
 
Email
mdctspd@nus.edu.sg
 
Other emails
 

Publications

Refined By:
Date Issued:  [2020 TO 2023]

Results 1-20 of 24 (Search time: 0.013 seconds).

Issue DateTitleAuthor(s)
11-Aug-2020A multicenter phase II randomized trial of durvalumab (MEDI-4736) versus physician's choice chemotherapy in recurrent ovarian clear cell adenocarcinoma (MOCCA)Ngoi, Natalie YL; Heong, Valerie; Ow, Samuel ; Chay, Wen Yee ; Kim, Hee Seung; Choi, Chel Hun; Goss, Geraldine; Goh, Jeffrey C; Tai, Bee Choo ; Lim, Diana G ; Kaliaperumal, Nivashini; Au, Veonice B; Connolly, John E ; Kim, Jae-Weon; Friedlander, Michael; Kim, Kidong; Tan, David SP 
21-Mar-2022A phase 1 study of the safety, pharmacokinetics and pharmacodynamics of escalating doses followed by dose expansion of the selective inhibitor of nuclear export (SINE) selinexor in Asian patients with advanced or metastatic malignanciesHo, Jingshan ; Heong, Valerie; Yong, Wei Peng ; Soo, Ross ; Chee, Cheng Ean ; Wong, Andrea ; Sundar, Raghav; Thian, Yee Liang ; Gopinathan, Anil ; Pang, Mei Yan; Koe, Priscillia; Jeraj, Santhiay Nathan; Soe, Phyu Pyar; Soe, Mu Yar; Tang, Tiffany ; Ng, Matthew CH; Tai, David WM ; Tan, Tira JY ; Xu, Hongmei; Chang, Hua; Landesman, Yosef; Shah, Jatin ; Shacham, Sharon; Lee, Soo Chin ; Tan, Daniel SW ; Goh, Boon Cher ; Tan, David SP 
315-Apr-2023A Phase I, First-in-Human Study of PRL3-zumab in Advanced, Refractory Solid Tumors and Hematological MalignanciesChee, Cheng E ; Ooi, Melissa ; Lee, Soo-Chin ; Sundar, Raghav ; Heong, Valerie; Yong, Wei-Peng ; Ng, Chin Hin ; Wong, Andrea; Lim, Joline SJ ; Tan, David SP ; Soo, Ross ; Tan, Joshua TC; Yang, Song; Thura, Min; Al-Aidaroos, Abdul Qader; Chng, Wee Joo ; Zeng, Qi ; Goh, Boon-Cher 
42020A single-arm phase II study of olaparib maintenance with pembrolizumab and bevacizumab in BRCA non-mutated patients with platinum-sensitive recurrent ovarian cancer (OPEB-01)Lee, Yong Jae; Lim, Myong Cheol; Kim, Byoung-Gie; Ngoi, Natalie YL ; Choi, Chel Hun; Park, Sang-Yoon; Tan, David SP ; Go, Yunjung; Lee, Jung-Yun
51-Jul-2022A step towards the ambition of precision oncology in recurrent ovarian cancerWijaya, Silvana Talisa; Tan, David Shao Peng 
616-Feb-2023Clinical outcome and prognostic factors for Asian patients in Phase I clinical trialsLoh, Jerold; Wu, Jiaxuan; Chieng, Jenny; Chan, Aurora; Yong, Wei-Peng ; Sundar, Raghav ; Lee, Soo-Chin ; Wong, Andrea; Lim, Joline SJ ; Tan, David SP ; Soo, Ross ; Goh, Boon-Cher ; Tai, Bee-Choo ; Chee, Cheng E 
7Aug-2022Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroupVergote, Ignace; Gonzalez-Martin, Antonio; Lorusso, Domenica; Gourley, Charlie; Mirza, Mansoor Raza; Kurtz, Jean-Emmanuel; Okamoto, Aikou; Moore, Kathleen; Kridelka, Frédéric; McNeish, Iain; Reuss, Alexander; Votan, Bénédicte; du Bois, Andreas; Mahner, Sven; Ray-Coquard, Isabelle; Kohn, Elise C; Berek, Jonathan S; Tan, David SP ; Colombo, Nicoletta; Zang, Rongyu; Concin, Nicole; O'Donnell, Dearbhaile; Rauh-Hain, Alejandro; Herrington, C Simon; Marth, Christian; Poveda, Andres; Fujiwara, Keiichi; Stuart, Gavin CE; Oza, Amit M; Bookman, Michael A; Mahner, Sven; Reuss, Alexander; du Bois, Andreas; Grimm, Christoph; Marth, Christian; Berger, Regina; Concin, Nicole; Chang, Ting-Chang; Ochiai, Kazunori; Gebski, Val; Davis, Alison; Beale, Philip; Vergote, Ignace; Kridelka, Frédéric; Denys, Hannelore; Vandecaveye, Vincent; Cancido dos Reis, Francisco Jose; Del Pilar Estevez Diz, Maria; Stuart, Gavin; MacKay, Helen; Carey, Mark; Cibula, David; Dundr (path), Pavel; Dorigo, Oliver; Berek, Jonathan; O'Donnell, Dearbhaile; Saadeh, Abu; Boere, Ingrid; Lok, Christianne; Coronado, Pluvio; Ottevanger, Nelleke; Tan, David SP; Ng, Joseph; Gonzalez Martin, Antonio; Oaknin, Ana; Poveda, Andres; Perez Fidalgo, Alejandro; Rauh-Hain, Alejandro; Lu, Karen; López-Zavala, Carlos; Gómez-García, Eva María; Ray-Coquard, Isabelle; Paoletti, Xavier; Kurtz, Jean-Emmanuel; Joly, Florence; Votan, Bénédicte; Bookman, Michael; Moore, Kathleen; Arend, Rebecca; Fujiwara, Keiichi; Fujiwara, Hiroyuki; Hasegawa, Kosei; Bruchim, Ilan; Tsoref, Dalia; Oda, Katsutoshi; Okamoto, Aikou; Enomoto, Takayuki; Michel, Dayana; Kim, Hee-Seung; Lee, Jung-Yun; Mukhopadhyay, Asima; Katsaros, Dionyssios; Colombo, Nicoletta; Pignata, Sandro; Lorusso, Domenica; Scambia, Giovanni; Kohn, Elise; Lee, Jung-Min; McNeish, Iain; Nicum, Shibani; Farrelly, Laura; Sehouli, Jalid; Keller, Maren; Braicu, Elena; Bjørge, Line; Mirza, Mansoor Raza; Auranen, Annika; Welch, Stephen; Oza, Amit M; Heinzelmann, Viola; Gourley, Charlie; Roxburgh, Patricia; Herrington, C Simon; Glasspool, Ros; Zang, Rongyu; Zhu, Jianqing
82023Closing the gap for cervical cancer research in Vietnam: current perspectives and future opportunities: a report from the 5th Gynecologic Cancer InterGroup (GCIG) Cervical Cancer Research Network (CCRN) Education SymposiumPhan, Ngoc TH; Tran, Quy T; Nguyen, Nhan PT; Nguyen, Hang T; Tran, Linh DN; Pham, Viet C; Bennett, Katherine; Chavez-Blanco, Adriana; Plante, Marie; Suh, Dong Hoon; Nout, Remi; Tan, David SP 
95-Dec-2020Cost-effectiveness of olaparib versus routine surveillance in the maintenance setting for patients with BRCA-mutated advanced ovarian cancer after response to first-line platinum-based chemotherapy in SingaporeTan, David SP ; Chan, Jack Junjie ; Hettle, Robert; Ghosh, Wrik; Viswambaram, Amrita; Yu, Cindy Chen
10Jun-2021Development of poly(ADP-ribose) polymerase inhibitor and immunotherapy combinations: progress, pitfalls, and promisesPham, Melissa M; Ngoi, Natalie YL ; Peng, Guang; Tan, David SP ; Yap, Timothy A 
1131-Aug-2021GAGE mediates radio resistance in cervical cancers via the regulation of chromatin accessibilityNin, Dawn Sijin ; Wujanto, Caryn; Tan, Tuan Zea ; Lim, Diana ; Damen, J Mirjam A; Wu, Kuan-Yi; Dai, Ziyu Melvin ; Lee, Zheng-Wei ; Idres, Shabana Binte ; Leong, Yiat Horng; Jha, Sudhakar ; Ng, Joseph Soon-Yau ; Low, Jeffrey JH ; Chang, Shih-Chung; Tan, David Shao Peng ; Wu, Wei; Choo, Bok Ai ; Deng, Lih-Wen 
122020Identification of serum cytokine clusters associated with outcomes in ovarian clear cell carcinomaYabuno, A.; Matsushita, H.; Hamano, T.; Tan, T.Z. ; Shintani, D.; Fujieda, N.; Tan, D.S.P. ; Huang, R.Y.-J.; Fujiwara, K.; Kakimi, K.; Hasegawa, K.
1325-Apr-2023Intraperitoneal Carboplatin for Ovarian Cancer — A Phase 2/3 TrialNagao, Shoji; Fujiwara, Keiichi; Yamamoto, Kouji; Tanabe, Hiroshi; Okamoto, Aikou; Takehara, Kazuhiro; Saito, Motoaki; Fujiwara, Hiroyuki; Tan, David SP ; Yamaguchi, Satoshi; Adachi, Sosuke; Kikuchi, Akira; Hirasawa, Takeshi; Yokoi, Takeshi; Nagai, Tomonori; Sato, Toyomi; Kamiura, Shoji; Fujishita, Akira; Loong, Wong Wai ; Chan, Karen; Syks, Peter; Olawaye, Alexsander; Ryu, Sang-Young; Shigeta, Hiroyuki; Kondo, Eiji; Yokoyama, Yoshihito; Matsumoto, Takashi; Hasegawa, Kosei; Enomoto, Takayuki
14Aug-2023Newly diagnosed and relapsed epithelial ovarian cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upGonzález-Martín, A; Harter, P; Leary, A; Lorusso, D; Miller, RE; Pothuri, B; Ray-Coquard, I; Tan, DSP ; Bellet, E; Oaknin, A; Ledermann, JA
1529-Jun-2021PD-L1 Expressing Recurrent Clear Cell Carcinoma of the Vulva with Durable Partial Response to Pembrolizumab: A Case ReportSachdeva, Manavi; Ngoi, Natalie YL ; Lim, Diana ; Poon, Michelle LM ; Thian, Yee Liang ; Lim, Yi Wan; Lim, Siew Eng ; Tong, Pearl ; Lum, Jeffrey HY ; Ng, Joseph ; Ilancheran, Arunachalam ; Domingo, Efren J; Low, Jeffrey JH ; Tan, David SP 
1623-Feb-2022Phase Ib Dose-Finding Study of Varlitinib Combined with Weekly Paclitaxel With or Without Carboplatin +/- Trastuzumab in Advanced Solid TumorsLee, Matilda Xinwei; Wong, Andrea LA ; Ow, Samuel; Sundar, Raghav ; Tan, David SP ; Soo, Ross A ; Chee, Cheng Ean ; Lim, Joline SJ ; Yong, Wei Peng ; Lim, Siew Eng; Goh, Boon Cher ; Wang, Lingzhi ; Lee, Soo Chin 
171-Jun-2022Phase Ib/II Dose Expansion Study of Lenvatinib Combined with Letrozole in Postmenopausal Women with Hormone Receptor–Positive Breast CancerLim, JSJ ; Wong, ALA ; Ow, SGW ; Ngoi, NYL ; Chan, GHJ; Ang, YLE; Chong, WQ; Lim, SE ; Lim, YW; Lee, M; Choo, JRE; Tan, HL; Yong, WP ; Soo, RA ; Tan, DSP ; Chee, CE ; Sundar, R ; Yadav, K ; Jain, S ; Wang, L ; Tai, BC ; Goh, BC ; Lee, SC 
1824-Sep-2021Statistical Process Control Charts for Monitoring Next-Generation Sequencing and Bioinformatics Turnaround in Precision Medicine InitiativesJain, Sneha Rajiv; Sim, Wilson; Ng, Cheng Han; Chin, Yip Han; Lim, Wen Hui; Syn, Nicholas L.; Kamal, Nur Haidah Bte Ahmad; Gupta, Mehek; Heong, Valerie; Lee, Xiao Wen; Sapari, Nur Sabrina ; Koh, Xue Qing; Isa, Zul Fazreen Adam ; Ho, Lucius; O’Hara, Caitlin; Ulagapan, Arvindh; Gu, Shi Yu; Shroff, Kashyap; Weng, Rei Chern; Lim, Joey S. Y.; Lim, Diana ; Pang, Brendan ; Ng, Lai Kuan ; Wong, Andrea ; Soo, Ross Andrew ; Yong, Wei Peng ; Chee, Cheng Ean; Lee, Soo-Chin ; Goh, Boon-Cher ; Soong, Richie ; Tan, David S. P. 
19Jun-2021Targeting the replication stress response through synthetic lethal strategies in cancer medicineNgoi, Natalie YL ; Pham, Melissa M; Tan, David SP ; Yap, Timothy A 
202023The effect of inhibition of receptor tyrosine kinase AXL on DNA damage response in ovarian cancerYeo, Xun Hui; Sundararajan, Vignesh ; Wu, Zhengwei ; Phua, Zi Jin Cheryl; Ho, Yin Ying; Peh, Kai Lay Esther; Chiu, Yi-Chia; Tan, Tuan Zea ; Kappei, Dennis ; Ho, Ying Swan; Tan, David Shao Peng ; Tam, Wai Leong ; Huang, Ruby Yun-Ju